Mechanisms of interstitial fibrosis in obstructive nephropathy

Seminars in Nephrology

Volumn 18, Issue 6, 1998, Pages 594-602

  Diamond, Jonathan R ^a   Ricardo, Sharon D ^b   Klahr, Saulo ^b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; FIBROSIS; HYDRONEPHROSIS; INFLAMMATION; KIDNEY BLOOD FLOW; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; MACROPHAGE; NONHUMAN; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; URETER LIGATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; KIDNEY TUBULES; OSTEOPONTIN; RATS; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SIALOGLYCOPROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; URETERAL OBSTRUCTION;

EID: 0031766270     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1:363-366, 1968
2. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. Part II: The correlations. Human Pathol 1:631-640, 1970
3. Striker GE, Schainuck LI, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. Part I. A method for assaying and classifying histologic changes in renal disease. Human Pathol 1:615-630, 1970
4. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
5. Fine LG, Ong ACM, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal disease. Eur J Clin Invest 23:259-265, 1993
6. Jones CL, Buch S, Post M, et al: Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am J Pathol 141:1381-1396, 1991
7. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney disease. Am J Physiol 266:F829-F842, 1994
8. Alverez RJ, Sun MJ, Haverty TP, et al: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 41:14-23, 1992
9. Humes HD, Cieslinski DA: Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 201:8-15, 1992
10. Ding G, Pesek-Diamond I, Diamond JR: Cholesterol, macrophages, and the gene expression of transforming growth factor-β1 and fibronectin during nephrosis. Am J Phys 264:F577-584, 1993
11. Tanaka K, Okuda S, Ando T, et al: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
12. Young BA, Johnson RJ, Alpers CE, et al: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
13. Bollineni JS, Reddi AS: Transforming growth factorβ1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42:1673-1677, 1993
14. Coimbra T, Wiggins R, Noh JW, et al: Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
15. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
16. Walton G, Buttyan R, Garcia-Montes E, et al: Renal growth factor expression during the early phase of experimental hydronephrosis. J Urol 148:510-514, 1992
17. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-β 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993
18. Diamond JR, Kees-Folts D, Ding G, et al: Macrophages, monocyte chemoattractant peptide-1 and TGF-β1 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
19. Diamond JR, Levinson M, Kreisberg R, Ricardo SD: Increased expression of decorin in experimental hydronephrosis. Kidney Int 51:1133-1139, 1997
20. Pimentai JL, Sundell CL, Wang S, et al: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
21. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:21452154, 1991
22. Davies M, Martin J, Thomas GJ: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
23. Kleiner DE, Stetler-Stevenson: Structural biochemistry and activation of matrix metalloproteinases. Curr Biol 5:891-897, 1993
24. Bauer EA, Cooper TW, Huang JS, et al: Stimulation of in vitro human skin collagenase expression by plateletderived growth factor. Proc Natl Acad Sci USA 82:4132-4136, 1985
25. Presta M, Moscatelli D, Joseph-Silverstein J, Rifkin DB: Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration. Mol Cell Biol 6:4060-4066, 1986
26. Chandrasekhar S, Harvey AK: Transforming growth factor-β is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 157:1352-1359, 1988
27. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597-641, 1990
28. Nomura S, Hogan BL, Wills AJ, et al: Developmental expression of tissue inhibitor of metalloproteinase (TIMP). RNA 105:575-583, 1989
29. Engelmyer E, van Goor H, Edwards DR, Diamond JR: Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. J Am Soc Nephrol 5:1675-1683, 1995
30. Sharma AK, Mauer SM, Kim Y, Michael AF: Altered expression of matrix metalloproteinase-2, TIMP, and TIMP2 in obstructive nephropathy. J Lab Clin Med 125:754-761, 1995
31. Bond JS, Butler PE, Beynon RJ: Metalloendopeptidases of the mouse kidney brush border: Meprin and endopeptidase-24.11. Biomed Biochim Acta 45:1515-1521, 1986
32. Ricardo SD, Bond JS, Kaspar J, et al: Down-regulated expression of meprin in experimental hydronephrosis. Am J Pathol 36:F669-F676, 1996
33. Border WA, Okuda S, Languino LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β 1. Nature 346: 371-374, 1990
34. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of mesangial extracellular matrix. J Clin Invest 86:454-462, 1990
35. Border WA, Noble NA, Yamamoto T, et al: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
36. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
37. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 123:104-111, 1993
38. Vyalov S, Desmouliere A, Gabbiani G: GM-CSF-induced granulation tissue formation: Relationships between macrophage and myofibroblast accumulation. Virchs Arch B Cell Pathol 63:231-239, 1993
39. Johnson RJ, Alpers CE, Yoshimura A, et al: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
40. Alpers CE, Hudkins KL, Floege J, Johnson RJ: Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 5:201-210, 1994
41. Diamond JR, van Goor H, Ding G, Engelmyer E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
42. Klahr S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. The modulation of macrophage migration and eicosanoid metabolism. Am J Kidney Dis 18:689-699, 1994
43. Purkerson M, Klahr S: Prior inhibition of vasoconstrictors normalizes GFR in postobstructed kidneys. Kidney Int 35:1305-1314, 1989
44. Blackshear JL, Wathen RL: Effects of indomethacin on renal blood flow and renin secretory responses to ureteral occlusion in the dog. Miner Electrolyte Metab 1:271-278, 1978
45. Harris RC, Becker BN, Cheng HF: Acute and chronic mechanisms for regulating proximal tubule angiotensin II receptor expression. J Am Soc Nephrol 8:306-313, 1997
46. Yamada H, Sexton PM, Chai SY, et al: Angiotensin II receptors in the kidneys: Localization and physiological significance. Am J Hypertens 3:250-255, 1990
47. Pimentai JL Jr, Martinez-Maldonado M, Wilcox JN, et al: Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int 44:390-400, 1993
48. Froklaer J, Knudsen J, Nielsen AS, et al: Enhanced intrarenal angiotensin II generation in response to obstruction of the pig ureter. Am J Physiol 263:F527-F533, 1992
49. Pimentai JL, Wang S, Martinez-Maldonado M: Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. Kidney Int 45:1614-1621, 1994
50. Pimentel JL Jr, Montera A, Wang S, et al: Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction. Kidney Int 48:1247-1253, 1995
51. El-Dahr SS, Gee J, Dipp S, et al: Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. Am J Physiol 264:F874-F881, 1993
52. Ingelfinger R, Dzau VJ: Molecular biology of renal injury: Emphasis on the role of the renin-angiotensin system. J Am Soc Nephrol 2:S9-S20, 1991
53. Burns KD, Homma T, Harris RC: The intrarenal reninangiotensin system. Semin Nephrol 13:13-20, 1993
54. Tank JE, Moe OW, Star RA, Henrich WL: Differential regulation of rat glomerular and proximal tubular renin mRNA following uninephrectomy. Am J Physiol 270:F776-F783, 1996
55. Seikaly MG, Arant BS Jr, Seney FD Jr: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352-1357, 1990
56. Ishidoya S, Morrissey J, McCracken R, et al: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
57. Klahr S, Morrissey JJ: Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int 52:S111-S114, 1997 (suppl 63)
58. Morrissey JJ, Klahr S: Differential effects of ACE and ATI receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol 274:F580-F586, 1998
59. Morrissey JJ, Ishidoya S, McCracken R, Klahr S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7:2202-2212, 1996
60. Lefkowith JB, Okegawa T, DeSchryver-Kecskemeti K, Needleman P: Macrophage-dependent arachidonate metabolism in hydronephrosis. Kidney Int 26:10-17, 1984
61. Rovin BH, Harris KP, Morrison A, et al: Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab Invest 63:213-220, 1990
62. Schreiner GF, Harris KP, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988
63. Diamond JR, Kees-Folts D, Ricardo SD, et al: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466, 1995
64. Ricardo SD, Levinson ME, DeJoseph MR, Diamond JR: Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int 50:20022010, 1996
65. Giachelli CM, Pichler R, Lombardi D, et al: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524, 1994
66. Pichler RH, Franceschini N, Young BA, et al: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
67. Gottschalk CW, Mylle M: Micropuncture study of pressures in proximal tubules and pertubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol 185:430-442, 1956
68. Collins T: Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993
69. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141179, 1994
70. Wendt T, Zhang YM, Bierhaus A, et al: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
71. Morrissey JJ, Klahr S: Rapid communication. Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997